Search

Your search keyword '"Cardiovascular diseases -- Development and progression -- Care and treatment"' showing total 41 results
Start Over Descriptor "Cardiovascular diseases -- Development and progression -- Care and treatment"
41 results on '"Cardiovascular diseases -- Development and progression -- Care and treatment"'

1. Study Findings from University of Texas Health San Antonio Advance Knowledge in Blood Pressure (Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial)

Subjects
Management, Evaluation, Care and treatment, Usage, Analysis, Development and progression, Company business management, Mortality -- Analysis -- United States, Diuretics -- Usage -- Evaluation, Cardiovascular diseases -- Development and progression -- Care and treatment, Blood pressure -- Management
Abstract

2024 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on blood pressure have been published. According to news [...]

Published
2024

2. Findings from Mason School of Business Provide New Insights into Telenursing (Telenursing and Remote Patient Monitoring In Cardiovascular Health)

Subjects
Technology application, Care and treatment, Development and progression, Methods, Home care -- Methods, Telemedicine -- Methods, Nursing care -- Methods -- Technology application, Physiologic monitoring -- Methods, Cardiac patients -- Care and treatment, Cardiovascular diseases -- Development and progression -- Care and treatment, Patient monitoring -- Methods
Abstract

2024 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Telemedicine - Telenursing. According to news originating [...]

Published
2024

3. Reports from Charite University Hospital and School of Medicine Describe Recent Advances in Cardiology [Protocol of the Berlin Long-term Observation of Vascular Events (BeLOVE): a prospective cohort study with deep phenotyping and long-term ...]

Subjects
Care and treatment, Analysis, Development and progression, Methods, Phenotypes -- Analysis, Health risk assessment -- Methods, Cardiovascular diseases -- Development and progression -- Care and treatment, Phenotype -- Analysis
Abstract

2023 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on cardiology are discussed in a new report. According to [...]

Published
2023

4. National Medical Research Center for Therapy and Preventive Medicine Researchers Update Current Data on Type 2 Diabetes (Cognitive-behavioral group therapy for obesity to reduce cardiovascular risks in patients with type 2 diabetes)

Subjects
Care and treatment, Development and progression, Obesity -- Development and progression -- Care and treatment, Type 2 diabetes -- Development and progression -- Care and treatment, Diabetes therapy, Medical research, Body weight, Cardiovascular diseases -- Development and progression -- Care and treatment, Group counseling, Medicine, Experimental
Abstract

2024 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- Data detailed on type 2 diabetes have been presented. According to news originating [...]

Published
2024

5. Researchers from Hospital Universitario Nuestra Senora de Candelaria Report Recent Findings in Type 2 Diabetes (Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a ...)

Subjects
Care and treatment, Analysis, Development and progression, Reports, Atherosclerosis -- Care and treatment -- Development and progression, Pentoxifylline -- Reports -- Analysis, Type 2 diabetes -- Care and treatment -- Development and progression, Cardiovascular diseases -- Development and progression -- Care and treatment, Chronic kidney failure -- Development and progression -- Care and treatment
Abstract

2024 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Current study results on type 2 diabetes have been published. According to news reporting originating [...]

Published
2024

6. Findings from Hamdard University Provide New Insights into Antioxidants (Cardioprotective effect of 2-methoxy phenol derivatives against oxidative stress-induced vascular complications: An integrated in vitro, in silico, and in vivo ...)

Subjects
Control, Care and treatment, Usage, Physiological aspects, Development and progression, Health aspects, Phenol (Compound) -- Usage -- Physiological aspects -- Health aspects, Oxidative stress -- Health aspects -- Control, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

2023 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on antioxidants have been published. According to news reporting [...]

Published
2023

7. Reports Summarize Cardiovascular Diseases and Conditions Study Results from Bina Nusantara University (Hyperparameter optimization for cardiovascular disease data-driven prognostic system)

Subjects
Management, Care and treatment, Evaluation, Development and progression, Company business management, Prognosis -- Evaluation, Medical records -- Management, Health risk assessment -- Evaluation, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

2023 AUG 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in cardiovascular diseases and conditions. According to news [...]

Published
2023

8. Research on Cardiovascular Diseases and Conditions Described by a Researcher at University Hospital Rio Hortega (Modified Sequential Organ Failure Assessment Score vs. Early Warning Scores in Prehospital Care to Predict Major Adverse Cardiac ...)

Subjects
Care and treatment, Prevention, Development and progression, Risk factors, Heart failure -- Risk factors -- Prevention, Hospital patients -- Care and treatment, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

2023 MAR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on cardiovascular diseases and conditions are discussed in a new [...]

Published
2023

9. New Findings from Shahid Beheshti University of Medical Sciences in the Area of Pharmacology Published (Endoplasmic reticulum as a target in cardiovascular diseases: Is there a role for flavonoids?)

Subjects
Care and treatment, Usage, Physiological aspects, Development and progression, Health aspects, Flavonoids -- Usage -- Physiological aspects -- Health aspects, Cardiovascular diseases -- Development and progression -- Care and treatment, Endoplasmic reticulum -- Health aspects -- Physiological aspects, Bioflavonoids -- Usage -- Physiological aspects -- Health aspects, Flavones -- Usage -- Physiological aspects -- Health aspects
Abstract

2023 JAN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on pharmacology have been published. According to news reporting [...]

Published
2023

10. Researchers from Southern Medical University Detail New Studies and Findings in the Area of Chronic Kidney Disease (Dietary choline, via gut microbe- generated trimethylamine-N- oxide, aggravates chronic kidney disease-induced cardiac ...)

Subjects
Care and treatment, Complications and side effects, Development and progression, Health aspects, Toxins -- Health aspects, Kidney diseases -- Complications and side effects -- Care and treatment, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

2022 NOV 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on chronic kidney disease have been published. According to [...]

Published
2022

11. Researchers at Harvard Medical School Report New Data on Arteriosclerosis Thrombosis and Vascular Biology (Expression of Cd70 Modulates Nitric Oxide and Redox Status In Endothelial Cells)

Subjects
Diagnosis, Care and treatment, Analysis, Development and progression, Properties, Nitric oxide -- Properties, Arteriosclerosis -- Diagnosis -- Care and treatment, Cardiovascular diseases -- Development and progression -- Care and treatment, Reactive oxygen species -- Analysis
Abstract

2022 SEP 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Cardiovascular Diseases and Conditions - Arteriosclerosis Thrombosis and Vascular [...]

Published
2022

12. China NMPA approves AstraZeneca's Forxiga to treat CKD in patients at risk of progression with and without type-2 diabetes

Subjects
AstraZeneca PLC, Diseases, Care and treatment, Development and progression, Type 2 diabetes -- Care and treatment -- Development and progression, Dapagliflozin, Pharmaceutical industry, Cardiovascular diseases -- Development and progression -- Care and treatment, Chronic kidney failure -- Development and progression -- Care and treatment
Abstract

AstraZeneca's Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in China to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), [...]

Published
2022

13. New Obesity Study Findings Have Been Reported by Investigators at University of Connecticut (A Novel Strategy To Dissect Multifaceted Macrophage Function In Human Diseases)

Subjects
Testing, Care and treatment, Development and progression, Health aspects, Macrophages -- Health aspects, Immune response -- Testing, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

2022 JUL 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Obesity [...]

Published
2022

14. Research on Pharmacology Detailed by Researchers at Affiliated Hospital of Zunyi Medical University (Icariside II Restores Vascular Smooth Muscle Cell Contractile Phenotype by Enhancing the Focal Adhesion Signaling Pathway in the Rat Vascular ...)

Subjects
Testing, Care and treatment, Physiological aspects, Development and progression, Glycosides -- Testing, Vascular smooth muscle -- Physiological aspects, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

2022 JUL 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on pharmacology is now available. According to news reporting [...]

Published
2022

15. Data on Dilated Cardiomyopathy Reported by Researchers at Guangzhou University of Chinese Medicine (Mechanism of Angiotensin-converting Enzyme Inhibitors In the Treatment of Dilated Cardiomyopathy Based On a Protein Interaction Network and ...)

Subjects
Care and treatment, Development and progression, Angiotensins, Medical research, Asian medicine, Cardiovascular diseases -- Development and progression -- Care and treatment, Congestive cardiomyopathy -- Care and treatment -- Development and progression, Angiotensin converting enzyme inhibitors, Cardiomyopathy, Dilated -- Care and treatment -- Development and progression, Medicine, Experimental, Medicine, Oriental, ACE inhibitors, Angiotensin
Abstract

2024 JAN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Current study results on Heart Disorders and Diseases - Dilated Cardiomyopathy have been published. According [...]

Published
2024

16. Findings on Cardiovascular Diseases and Conditions Detailed by Investigators at Stanford University (Non-exercise Estimated Cardiorespiratory Fitness and Mortality From All-causes, Cardiovascular Disease, and Cancer In the Nih-aarp Diet and ...)

Subjects
Care and treatment, Development and progression, Health aspects, Forecasts and trends, Market trend/market analysis, Mortality -- Forecasts and trends, Physical fitness -- Health aspects, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

2022 MAY 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Cardiovascular Diseases and Conditions have been published. According [...]

Published
2022

17. Studies from Second Affiliated Hospital of Harbin Medical University in the Area of Cardiovascular Diseases and Conditions Published (Ferroptosis: A Potential Target in Cardiovascular Disease)

Subjects
Care and treatment, Development and progression, Research, Cardiovascular research, Cell death -- Research, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

2022 FEB 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on cardiovascular diseases and conditions is now available. According [...]

Published
2022

18. Guangzhou University of Chinese Medicine Reports Findings in Dilated Cardiomyopathy (Mechanism of angiotensin-converting enzyme inhibitors in the treatment of dilated cardiomyopathy based on a protein interaction network and molecular docking)

Subjects
Cardiomyopathy, Dilated -- Care and treatment -- Development and progression, Medical research -- Reports, Medicine, Experimental -- Reports, Medicine, Oriental -- Reports, ACE inhibitors -- Reports, Cardiovascular diseases -- Development and progression -- Care and treatment, Angiotensin -- Reports, Computers, News, opinion and commentary
Abstract

2023 JUL 19 (VerticalNews) -- By a News Reporter-Staff News Editor at Computer Weekly News -- New research on Heart Disorders and Diseases - Dilated Cardiomyopathy is the subject of [...]

Published
2023

19. Research from Karolinska Institute Provides New Data on Chronic Kidney Disease (Lifelong statins for long life in dialysis patients?)

Subjects
Care and treatment, Development and progression, Statins, Medical research, Cardiovascular agents, Cardiovascular diseases -- Development and progression -- Care and treatment, Chronic kidney failure -- Development and progression -- Care and treatment, Medicine, Experimental
Abstract

2023 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on chronic kidney disease is the subject of a new report. [...]

Published
2023

20. Q / Does niacin decrease cardiovascular morbidity and mortality in CVD patients?

Author

Lazzopina, Peter, Mounsey, Anne, and Handler, Lara

Subjects
Care and treatment, Development and progression, Health aspects, Niacin -- Health aspects, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

EVIDENCE--BASED ANSWER A / NO. Niacin doesn't reduce cardio-vascular disease (CVD) morbidity or mortality in patients with established disease (strength of recommendation [SOR]: A, meta-analyses of randomized controlled trials [RCTs] [...]

Published
2018

21. Data on Cardiovascular Diseases and Conditions Described by Researchers at Montefiore Medical Center (Anti-inflammatory Therapy for Cardiovascular Disease)

Subjects
Montefiore Medical Center, Care and treatment, Development and progression, Tumor necrosis factor, Anti-inflammatory agents, Atherosclerosis -- Development and progression -- Care and treatment, Physical fitness, Medical centers, C-reactive protein, Medical research, Cardiovascular diseases -- Development and progression -- Care and treatment, Necrosis, Tumors, Obesity, Interleukins, Editors
Abstract

2019 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Cardiovascular Diseases and Conditions have been published. According [...]

Published
2019

22. Association between intake of less-healthy foods defined by the United Kingdom's nutrient profile model and cardiovascular disease: A population-based cohort study

Author

Mytton, Oliver T., Forouhi, Nita G., Scarborough, Peter, Lentjes, Marleen, Luben, Robert, Rayner, Mike, Khaw, Kay Tee, Wareham, Nicholas J., and Monsivais, Pablo

Subjects
Care and treatment, Development and progression, Health aspects, Cardiovascular diseases -- Development and progression -- Care and treatment, Diet -- Health aspects
Abstract

Author(s): Oliver T. Mytton 1, Nita G. Forouhi 1, Peter Scarborough 2, Marleen Lentjes 3, Robert Luben 3, Mike Rayner 2, Kay Tee Khaw 3, Nicholas J. Wareham 1, Pablo [...], Background In the United Kingdom, the Food Standards Agency-Ofcom nutrient profiling model (FSA-Ofcom model) is used to define less-healthy foods that cannot be advertised to children. However, there has been limited investigation of whether less-healthy foods defined by this model are associated with prospective health outcomes. The objective of this study was to test whether consumption of less-healthy food as defined by the FSA-Ofcom model is associated with cardiovascular disease (CVD). Methods and findings We used data from the European Prospective Investigation of Cancer (EPIC)-Norfolk cohort study in adults (n = 25,639) aged 40-79 years who completed a 7-day diet diary between 1993 and 1997. Incident CVD (primary outcome), cardiovascular mortality, and all-cause mortality (secondary outcomes) were identified using record linkage to hospital admissions data and death certificates up to 31 March 2015. Each food and beverage item reported was coded and given a continuous score, using the FSA-Ofcom model, based on the consumption of energy; saturated fat; total sugar; sodium; nonsoluble fibre; protein; and fruits, vegetables, and nuts. Items were classified as less-healthy using Ofcom regulation thresholds. We used Cox proportional hazards regression to test for an association between consumption of less-healthy food and incident CVD. Sensitivity analyses explored whether the results differed based on the definition of the exposure. Analyses were adjusted for age, sex, behavioural risk factors, clinical risk factors, and socioeconomic status. Participants were followed up for a mean of 16.4 years. During follow-up, there were 4,965 incident cases of CVD (1,524 fatal within 30 days). In the unadjusted analyses, we observed an association between consumption of less-healthy food and incident CVD (test for linear trend over quintile groups, p < 0.01). After adjustment for covariates (sociodemographic, behavioural, and indices of cardiovascular risk), we found no association between consumption of less-healthy food and incident CVD (p = 0.84) or cardiovascular mortality (p = 0.90), but there was an association between consumption of less-healthy food and all-cause mortality (test for linear trend, p = 0.006; quintile group 5, highest consumption of less-healthy food, versus quintile group 1, HR = 1.11, 95% CI 1.02-1.20). Sensitivity analyses produced similar results. The study is observational and relies on self-report of dietary consumption. Despite adjustment for known and reported confounders, residual confounding is possible. Conclusions After adjustment for potential confounding factors, no significant association between consumption of less-healthy food (as classified by the FSA-Ofcom model) and CVD was observed in this study. This suggests, in the UK setting, that the FSA-Ofcom model is not consistently discriminating among foods with respect to their association with CVD. More studies are needed to understand better the relationship between consumption of less-healthy food, defined by the FSA-Ofcom model, and indices of health.

Published
2018
Full Text
View/download PDF

23. Reports on Cardiovascular Diseases and Conditions Findings from Loughborough University Provide New Insights (Examining associations between physical activity and cardiovascular mortality using negative control outcomes)

Subjects
Development and progression, Care and treatment, Health aspects, Forecasts and trends, Market trend/market analysis, Cardiovascular diseases -- Development and progression -- Care and treatment, Exercise -- Health aspects, Quality of life -- Health aspects, Mortality -- Forecasts and trends
Abstract

2018 DEC 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Cardiovascular Diseases and Conditions is the subject of a [...]

Published
2018

24. AHA News: After Stroke, Heart Surgery and Heart Attack, Runner Vows to Reclaim Her Strength

Subjects
Observations, Care and treatment, Development and progression, Health aspects, Recovery of function -- Observations, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

FRIDAY, March 12, 2021 (American Heart Association News) -- Michelle Whiteman woke up and realized that her left arm felt numb. She figured it was a pinched nerve and made [...]

Published
2021

25. The future of care: Part I: the patient experience

Author

Aston, Geri

Subjects
Care and treatment, Development and progression, Cancer treatment, Cardiovascular diseases -- Development and progression -- Care and treatment, Cancer -- Care and treatment
Abstract

HEART DISEASE In 2020 a big 'gee whiz' factor in heart disease treatment will be process measures that make sure patients are getting needed therapies, says Edward Winslow, M.D., associate [...]

Published
2010

26. Cardiotoxicity associated with bortezomib: A single-center experience

Author

Gurram, Murali, Pulivarthi, Swaroopa, Ehresmann, Kirsten, and Mathew, Josy

Subjects
Care and treatment, Complications and side effects, Development and progression, Bortezomib -- Complications and side effects, Cardiovascular diseases -- Development and progression -- Care and treatment
Published
2017

27. New Chronic Kidney Disease Study Findings Have Been Reported by L.M. Blanco-Colio and Co-Researchers (Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease)

Subjects
Care and treatment, Development and progression, Physical fitness, Medical research, Cardiac patients -- Care and treatment, Cardiovascular diseases -- Development and progression -- Care and treatment, Chronic kidney failure -- Development and progression -- Care and treatment
Abstract

2017 JUN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Kidney Diseases and Conditions - Chronic Kidney Disease [...]

Published
2017

28. New Cardiovascular Diseases Study Findings Recently Were Reported by Researchers at University College Cork (Functional food addressing heart health: do we have to target the gut microbiota?)

Subjects
Care and treatment, Development and progression, Microbiota (Symbiotic organisms), Medical research, Target marketing, Cardiovascular diseases -- Development and progression -- Care and treatment, Functional foods
Abstract

2016 MAR 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Cardiovascular Diseases and Conditions. According to news [...]

Published
2016

29. PCSK9 inhibitors: Specific studies are mandatory to prove efficacy and safety in CKD

Subjects
Low density lipoproteins, Anticholesteremic agents, Medical research, Antilipemic agents, Kidney diseases -- Development and progression -- Care and treatment, EDTA, Cardiovascular diseases -- Development and progression -- Care and treatment, Mortality, Morbidity, Ezetimibe, Business, Business, international
Abstract

M2 PRESSWIRE-June 13, 2019-Presswire: PCSK9 inhibitors: Specific studies are mandatory to prove efficacy and safety in CKD (C)1994-2019 M2 COMMUNICATIONS RDATE:13062019 Budapest - -- High cardiovascular morbidity and mortality remain [...]

Published
2019

30. New Venous Thromboembolism Study Findings Recently Were Reported by S. Dubinsky and Co-Researchers (Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone)

Subjects
Management, Diseases, Care and treatment, Development and progression, Company business management, Prednisone, Abiraterone, Cancer research, Thromboembolism -- Development and progression -- Care and treatment, Anticoagulants, Glucocorticoids, Cardiovascular diseases -- Development and progression -- Care and treatment, Cancer metastasis -- Development and progression -- Care and treatment, Medical research, Editors
Abstract

2019 MAY 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Cardiovascular Diseases and Conditions - Venous Thromboembolism. According to news [...]

Published
2019

31. The Benefit of Cardio-Oncology Programs for Cancer Patients

Author

Ismail-Khan, Roohi

Subjects
Development and progression, Care and treatment, Physiological aspects, Cardiovascular diseases -- Development and progression -- Care and treatment, Cancer patients -- Physiological aspects, Toxicity, Mortality, Cardiac patients, Cancer treatment, Sunitinib, Bevacizumab, Antineoplastic agents, Morbidity, Cancer survivors
Abstract

Cardio-oncology is a cutting-edge, multidisciplinary field focusing on the management and prevention of cardiovascular complications in cancer patients and survivors. Although survival rates for cardiovascular disease and cancer have improved [...]

Published
2019

33. Stent Patients Face Higher Risk of Death After Bleeding, Clots; Prolonged treatment to prevent clots may increase bleeding risk in some patients, researchers warn

Subjects
Care and treatment, Development and progression, Patient outcomes, Forecasts and trends, Market trend/market analysis, Stents -- Patient outcomes, Mortality -- Forecasts and trends, Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

WEDNESDAY, March 15, 2017 (HealthDay News) -- More than a year after getting stents to prop open their clogged arteries, some patients are still at increased risk of death if [...]

Published
2017

34. Breakthrough could help sufferers of fatal lung disease

Subjects
Pulmonary hypertension -- Development and progression -- Care and treatment, Chambers of commerce, Lung diseases -- Development and progression -- Care and treatment, Cardiovascular diseases -- Development and progression -- Care and treatment, Business, international
Abstract

London: Sheffield Chamber of Commerce has issued the following news release: Pioneering research conducted by the University of Sheffield is paving the way for new treatments which could benefit patients [...]

Published
2016

35. XBiotech Receives Fast Track Designation from FDA for True Human(TM) Monoclonal Antibody Therapy Targeting Inflammatory Cytokine IL-1a for Restenosis

Subjects
Cytokines, Biopharmaceutics, Cardiovascular diseases -- Development and progression -- Care and treatment, Monoclonal antibodies, Business, News, opinion and commentary
Abstract

First Therapy for Treatment of Restenosis and Vascular Disease AUSTIN, Texas, Jan. 3, 2013 /PRNewswire/ -- XBiotech, a privately held biotechnology company, announced today that the company has been granted [...]

Published
2013

36. Folic acid plus [B.sub.12] does not improve CVD outcomes in high-risk patients

Author

Savill, Peter

Subjects
Care and treatment, Development and progression, Health aspects, Vitamin B12 -- Health aspects, Cardiovascular diseases -- Development and progression -- Care and treatment, Folic acid -- Health aspects
Abstract

Lowering homocysteine levels with folic acid and vitamin [B.sub.12] supplements does not reduce the risk of cardiovascular events or stroke in patients who have suffered an MI, a major study [...]

Published
2010

37. Aerpio Therapeutics Announces Publication of Data on Tie2 Activator, AKB-9778, Supporting Future Clinical Development in Cancer

Subjects
Harvard University. Harvard Medical School, Massachusetts General Hospital, Care and treatment, Development and progression, Cardiovascular diseases -- Development and progression -- Care and treatment, Breast cancer -- Development and progression -- Care and treatment
Abstract

By a News Reporter-Staff News Editor at Biotech Week -- Aerpio Therapeutics, a clinical-stage biopharmaceutical company developing innovative therapies for vascular diseases by targeting the Tie2 pathway, announced that collaborators [...]

Published
2013

38. Pharmacogenomics of cholesterol-lowering therapy is focus of review

Subjects
Care and treatment, Development and progression, Anticholesteremic agents, DNA, Pharmacogenomics, Cardiovascular agents, Cardiovascular diseases -- Development and progression -- Care and treatment, Pharmacogenetics
Abstract

The pharmacogenomics of cholesterol-lowering therapy is reviewed in a recen issue of Vascular Pharmacology. According to the review from Germany, 'The prevention of cardiovascular disease is critically dependent on lipid-lowering [...]

Published
2006

39. Pharmacogenomics of cholesterol-lowering therapy is focus of review

Subjects
Care and treatment, Development and progression, Anticholesteremic agents, DNA, Pharmacogenomics, Cardiovascular agents, Cardiovascular diseases -- Development and progression -- Care and treatment, Pharmacogenetics
Abstract

The pharmacogenomics of cholesterol-lowering therapy is reviewed in a recen issue of Vascular Pharmacology. According to the review from Germany, 'The prevention of cardiovascular disease is critically dependent on lipid-lowering [...]

Published
2006

40. Pharmacogenomics of cholesterol-lowering therapy is focus of review

Subjects
Care and treatment, Development and progression, Anticholesteremic agents, DNA, Pharmacogenomics, Cardiovascular agents, Cardiovascular diseases -- Development and progression -- Care and treatment, Pharmacogenetics
Abstract

The pharmacogenomics of cholesterol-lowering therapy is reviewed in a recen issue of Vascular Pharmacology. According to the review from Germany, 'The prevention of cardiovascular disease is critically dependent on lipid-lowering [...]

Published
2006

41. Heart and blood vessel disease

Subjects
Cardiovascular diseases -- Development and progression -- Care and treatment
Abstract

Warning Signs Of Heart Attack * Chest discomfort. Most heart attacks involve discomfort in the center of the chest that lasts more than a few minutes, or that goes aways […]

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results